Stronger effects can come with stronger side effects, higher costs, stricter monitoring, or long-term access issues
Tirzepatide vs Zepbound People looking into new weight loss treatments often get confused by the names of medications and their branded versions
Root cause of most GLP-1 problems in India: not the drug alone When you look carefully, most GLP-1 horror stories in India trace back to a few root causes: Wrong choice of patient (very low BMI, eating disorders, high-risk medical history) Buying and using drugs without a proper prescription or follow-up Rapid dose escalation to chase quick weight loss Not adjusting older diabetes medicines like sulfonylureas and insulin No guidance on diet, hydration, and muscle protection Fixing these root issues can sharply reduce GLP-1 side effects and make these medicines a safer, more useful ally in Indias diabetes and obesity epidemic
Barbour, MD, MSPH, FACP, professor in endocrinology, metabolism and diabetes and maternal-fetal medicine at University of Colorado
While AOD 9604 is considered to be a GRAS treatment
We want you to lose weight, yes, but we also want to correct the basic genetic etiology of the insulin resistance, and that is why we need new drugs in the insulin-resistance field, DeFronzo said